- Home
- GO vs PRCT Comparison
GO vs PRCT Comparison
Compare GO & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GO
- PRCT
- Stock Information
- Founded
- GO 1946
- PRCT 2009
- Country
- GO United States
- PRCT United States
- Employees
- GO N/A
- PRCT N/A
- Industry
- GO Food Chains
- PRCT Medical Specialities
- Sector
- GO Consumer Staples
- PRCT Health Care
- Exchange
- GO Nasdaq
- PRCT Nasdaq
- Market Cap
- GO 1.7B
- PRCT 1.8B
- IPO Year
- GO 2019
- PRCT 2021
- Fundamental
- Price
- GO $15.18
- PRCT $35.34
- Analyst Decision
- GO Hold
- PRCT Buy
- Analyst Count
- GO 12
- PRCT 8
- Target Price
- GO $17.17
- PRCT $67.14
- AVG Volume (30 Days)
- GO 2.5M
- PRCT 1.1M
- Earning Date
- GO 11-04-2025
- PRCT 11-04-2025
- Dividend Yield
- GO N/A
- PRCT N/A
- EPS Growth
- GO N/A
- PRCT N/A
- EPS
- GO 0.08
- PRCT N/A
- Revenue
- GO $4,511,376,000.00
- PRCT $274,950,000.00
- Revenue This Year
- GO $11.29
- PRCT $48.38
- Revenue Next Year
- GO $5.59
- PRCT $30.87
- P/E Ratio
- GO $182.14
- PRCT N/A
- Revenue Growth
- GO 8.47
- PRCT 55.71
- 52 Week Low
- GO $10.26
- PRCT $32.11
- 52 Week High
- GO $21.67
- PRCT $103.81
- Technical
- Relative Strength Index (RSI)
- GO 40.81
- PRCT 50.91
- Support Level
- GO $15.04
- PRCT $34.32
- Resistance Level
- GO $15.76
- PRCT $36.69
- Average True Range (ATR)
- GO 0.55
- PRCT 1.73
- MACD
- GO 0.02
- PRCT 0.41
- Stochastic Oscillator
- GO 18.18
- PRCT 82.10
About GO Grocery Outlet Holding Corp.
Grocery Outlet Holding Corp is a grocery store operator in the United States. It is a retailer of quality, name-brand consumables and fresh products sold through a network of independently operated stores. The stores are run by Entrepreneurial independent operators which create a neighborhood feel through personalized customer service and a localized product offering.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.